Global epidemiology and burden of schizophrenia: Findings from the global burden of disease study 2016

Schizophrenia Bulletin

Volumn 44, Issue 6, 2018, Pages 1195-1203

  Charlson, Fiona J ^a,b,c   Ferrari, Alize J ^a,b,c   Santomauro, Damian F ^a,b,c   Diminic, Sandra ^a,b   Stockings, Emily ^d   Scott, James G ^a,b,e   McGrath, John J ^a,b,f   Whiteford, Harvey A ^a,b,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND CENTRE FOR MENTAL HEALTH RESEARCH   (Australia)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^f AARHUS UNIVERSITY   (Denmark)

Author keywords

Burden of disease; Epidemiology; Mental health; Schizophrenia

Indexed keywords

ARTICLE; DISABILITY; GLOBAL DISEASE BURDEN; GROUPS BY AGE; HUMAN; INCIDENCE; MORTALITY; POPULATION GROWTH; PREVALENCE; PRIORITY JOURNAL; REMISSION; SCHIZOPHRENIA; SYSTEMATIC REVIEW; ADULT; FEMALE; MALE; MIDDLE AGED; STATISTICS AND NUMERICAL DATA;

ADULT; FEMALE; GLOBAL BURDEN OF DISEASE; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA;

EID: 85051429479     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sby058     Document Type: Article

References (37)

1. Jääskeläinen E, Juola P, Hirvonen N, et al. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2012;39:1296-1306.
2. Laursen TM, Nordentoft M, Mortensen PB. Excess early mortality in schizophrenia. Annu Rev Clin Psychol. 2014;10:425-448.
3. Charlson FJ, Baxter AJ, Dua T, Degenhardt L, Whiteford HA, Vos T. Excess mortality from mental, neurological and substance use disorders in the Global Burden of Disease Study 2010. Epidemiol Psychiatr Sci. 2015;24:121-140.
4. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 2007;64:1123-1131.
5. Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005;2:e141.
6. Murray C, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ. 1994;72:495.
7. Mathers C, Fat DM, Boerma JT. The Global Burden of Disease: 2004 Update. Geneva, Switzerland: World Health Organization; 2008.
8. Hay SI, Abajobir AA, Abate KH, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1260-1344.
9. Vos T, Abajobir AA, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211-1259.
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). 4th ed., revised. Washington, DC: American Psychiatric Association; 2000.
11. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization; 1992.
12. McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med. 2004;2:13.
13. Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
14. Stevens GA, Alkema L, Black RE, et al; GATHER Working Group. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. PLoS Med. 2016;13:e1002056.
15. Kruijshaar ME, Barendregt J, Vos T, de Graaf R, Spijker J, Andrews G. Lifetime prevalence estimates of major depression: an indirect estimation method and a quantification of recall bias. Eur J Epidemiol. 2005;20:103-111.
16. Moffitt TE, Caspi A, Taylor A, et al. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol Med. 2010;40:899-909.
17. Simon GE, Von Korff M. Recall of psychiatric history in cross-sectional surveys: implications for epidemiologic research. Epidemiol Rev. 1995;17:221-227.
18. Susser E, Shrout PE. Two plus two equals three? Do we need to rethink lifetime prevalence? A commentary on 'How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment' by Moffitt et al. (2009). Psychol Med. 2010;40:895-897.
19. Flaxman A, Murray C, Vos T, eds. Integrated MetaRegression Framework for Descriptive Epidemiology. Seattle, WA: University of Washington Press; 2015.
20. Global Burden of Disease Study Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743-800.
21. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163-2196.
22. Ferrari AJ, Saha S, McGrath JJ, et al. Health states for schizophrenia and bipolar disorder within the Global Burden of Disease 2010 Study. Popul Health Metr. 2012;10:16.
23. Salomon JA, Vos T, Hogan DR, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2012;380:2129-2143.
24. Haagsma JA, Maertens de Noordhout C, Polinder S, et al. Assessing disability weights based on the responses of 30,660 people from four European countries. Popul Health Metr. 2015;13:10.
25. Salomon JA, Haagsma JA, Davis A, et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health. 2015;3:e712-e723.
26. Burstein R, Fleming T, Haagsma J, Salomon JA, Vos T, Murray CJ. Estimating distributions of health state severity for the global burden of disease study. Popul Health Metr. 2015;13:31.
27. Wang H, Naghavi M, Allen C, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459-1544.
28. Demyttenaere K, Bruffaerts R, Posada-Villa J, et al; WHO World Mental Health Survey Consortium. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA. 2004;291:2581-2590.
29. Murray C, Lopez AD. Global Health Statistics: A Compendium of Incidence, Prevalence, and Mortality Estimates for over 200 Conditions. Cambridge: Harvard University Press; 1996.
30. Cooper J, Sartorius N. Mental disorders in China. Glasgow: Gaskell; 1996.
31. Liu T, Zhang L, Pang L, Li N, Chen G, Zheng X. Schizophrenia-related disability in China: prevalence, gender, and geographic location. Psychiatr Serv. 2015;66:249-257.
32. Zhang W, Shen Y, Li S, et al. Epidemiological survey on mental disorders in 7 areas in China. Chin J Psychiatry. 1998;31:69-71.
33. Phillips MR, Yang G, Li S, Li Y. Suicide and the unique prevalence pattern of schizophrenia in mainland China: a retrospective observational study. Lancet. 2004;364:1062-1068.
34. Mueser KT, McGurk SR. Schizophrenia. Lancet. 2004;363:2063-2072.
35. Knapp M, Mangalore R, Simon J. The global costs of schizophrenia. Schizophr Bull. 2004;30:279-293.
36. Hjorthøj C, Stürup AE, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017;4:295-301.
37. Lora A, Kohn R, Levav I, McBain R, Morris J, Saxena S. Service availability and utilization and treatment gap for schizophrenic disorders: a survey in 50 low- and middle-income countries. Bull World Health Organ. 2012;90:47-54, 54A.